The Steps Beyond the Science:Challenges in bringing global health products to market in a sustainable way

New and improved medicines and vaccines remain vital to addressing unmet global health needs in the developing world. And it is critical to ensure sustainable, timely and effective pathways to market these products such that their impact is realised.

Regulatory, policy, financing, infrastructure and workforce gaps in the global health architecture complicate these pathways. Such gaps risk the value of and incentive for this innovation being undermined and will impede our collective ability to achieve the SDG targets, including the global goal of Universal Health Coverage.

Timed to coincide with the World Health Assembly, our discussion will focus on the present-day hurdles for different partners in these pathways, drawing on real case studies.

By bringing together stakeholders from across global health networks – from industry, policy-makers, governments and civil society – we will share learnings and identify major challenges and opportunities for improving the pathways, partnerships and risk-sharing models involved in sustainable market access. And we will ask all partners present to take these insights forward for the global health products in existence in order to catalyse access and make a difference to lives around the world.